Glioblastoma
The phase I glioblastoma clinical trial is now closed and results have been published in the Journal of Clinical Neuroscience:
https://www.sciencedirect.com/science/article/pii/S0967586821005713
The results have also been subject to a Newshub item recently:
https://www.newshub.co.nz/home/new-zealand/2021/12/wellington-researchers-believe-cocktail-of-common-medicines-could-extend-lives-of-glioblastoma-patients.html
The GMRI is currently fundraising for a phase II glioblastoma clinical trial. Further information is available by clicking the link below:
https://gmri.org.nz/cms/our-phase-i-glioblastoma-clinical-trial-is-complete-lets-start-our-phase-ii-clinical-trial/
For further information, please contact;
please contact Ruth Watson-Black, GMRI Study Coordinator
Email: ruth.watson-black@gmri.org.nz
Phone: GMRI mainline: 04 282 0366
Supporting charity
https://www.braintumoursupport.org.nz/
Articles on the trial
https://gmri.org.nz/cms/results-of-our-phase-i-glioblastoma-clinical-trial/
https://gmri.org.nz/cms/our-clinical-trials-are-making-steady-progress/
https://www.braintumoursupport.org.nz/our-latest-news/2020/10/23/changing-the-way-we-think-about-cancer
https://www.stuff.co.nz/national/health/105072099/potential-solution-to-aggressive-cancers-being-developed-by-wellington-researchers
https://gmri.org.nz/cms/new-cancer-treatment-for-glioblastoma-a-devastating-brain-cancer/
